Trump tariffs will raise US generic drug prices, warns Dr Reddy's CEO

The CEO of Indian pharmaceutical giant Dr Reddy's has warned that proposed Trump administration tariffs on generic drugs will result in higher prices for US patients. India is one of the largest suppliers of affordable generic medicines to the American market. The tariffs would hit lower-income patients hardest, as they rely most on cheaper generic alternatives to branded drugs.